Roelof Rongen

Mr. Rongen is a serial entrepreneur, company builder and R&D/Commercial Development leader., now: co-Founder and Board Director of AeirBio, a biotech focused on treating solid tumors;Board Director of GRI Bio;CEO of Adolore BioThereapeutics, gene-therapy for Chronic Pain. Prior, he founded Matinas BioPharma with IPO to NYSE:MTNB;he led the development/launch preparations of blockbusters Humira® and Lovaza®.